Pfizer/BioNTech COVID-19 Booster Shots Get Recommendation From European Medicine Agency - Moderna (NASDAQ:MRNA), Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX)

The European Medicine Agency's Committee for Medicinal Products for Human Use has recommended COVID-19 booster shots from Pfizer Inc PFE and BioNTech SE BNTX for adults 18 years and older.
Related: Johnson & Johnson To Seek FDA Approval For COVID-19 Booster Shot: Report.
The CHMP said its recommendation was based on studies showing that a third dose increased antibody levels.
The Committee concluded that booster doses might be considered at least six months after the second dose.
The advisory group is still reviewing data on Moderna Inc's MRNA COVID-19 shot booster doses.
The CHMP also recommended booster shots for both the Pfizer/BioNTech vaccine and the Moderna vaccine for those who are immunocompromised, at least 28 days after their second dose.
Related: Is Moderna's COVID-19 Booster Shot Moving Closer To Authorization?
Price Action: PFE stock closed down 1.19% at $42.42, BNTX stock down 2.31% at $248.90, and MRNA fell 4.47% at $325.84 on Monday.
Photo by x3 from Pixabay